We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India.
- Authors
Padmanabhan, Swathi; Amin, Tahir; Sampat, Bhaven; Cook-Deegan, Robert; Chandrasekharan, Subhashini
- Abstract
The article investigates the extend to which patents are a barrier to producing human papilloma virus (HPV) vaccines in low- and middle-income countries (LMC), especially in India. Researchers believe that intellectual property (IP) does not preclude manufacturing of first-generation LI major capsid antigen virus-like particles (LI-VLP)-based vaccines unless they are similar in formulation or strain coverage to those compositions claimed in granted Indian patents. They believe that additional know-how is also imperative in the development of new vaccines.
- Subjects
INDIA; PATENTS; HUMAN papillomavirus vaccines; INTELLECTUAL property; MIRIDAE; VACCINES
- Publication
Nature Biotechnology, 2010, Vol 28, Issue 7, p671
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0710-671